EPAX De-Merges from Pronova Biocare

EPAX De-Merges from Pronova Biocare

LYSAKER, NorwayEPAX AS, formerly a division of Pronova Biocare,de-merged from the parent company to operate as a producer of concentratedomega-3 oils in the business-to-business segment. The companys location and executive team are unchanged, as are theproduction and manufacturing procedures and the brand marketing name, EPAX. Thecompany also has a GMP- (good manufacturing practice) approved productionfacility in Alesund, Norway.

We are excited about what our new structure means for our customers,said Bjorn Refsum, chief executive officer (CEO) at EPAX (www.epax.com). Asour own company, we are able to solely focus on producing the highest qualityomega-3 oils and have full control over tailoring the services we offer tocustomers.

According to Refsum, EPAX products posted a 25-percent growth rate in 2005,compared to an industry average of 8 percent reported by Frost & Sullivan.